Experimental study on the relationship between levodopa ⁃induced dyskinesia and phosphorylation of ERK in the striatum

Lu SONG, Yaping MA, Zhenguo LIU, Maowen BA, Leisi BIAN

Abstract


Objective To explore the relationship between levodopa⁃induced dyskinesia (LID) and phosphorylated extracellular signal ⁃ regulated kinase (ERK, Thr202/Tyr204, ERK1/2) in striatum. Methods The hemiparkinsonian rat model was produced by stereotaxically injecting 6⁃hydroxydopamine (6⁃ OHDA) to right medial forebrain bundle (MFB). The hemiparkinsonian rats were intraperitoneally treated with levodopa (50 mg/kg) and benserazide (12.50 mg/kg) for 21 d and abnormal involuntary movement was evaluated. Immunofluorescent and Western blotting were used to observe the changes of phosphorylation of ERK1/2 in rat's striatum. Results Western blotting indicated that the 6 ⁃ OHDA lesion induced a significant downregulation of the phosphorylation of ERK1/2 to (68.28 ± 7.42)% in comparison with the sham⁃lesioned group [ (107.05 ± 3.81)% ; t = 0.109, P = 0.018]. Chronic treatment with levodopa significantly increased the phosphorylation of ERK1/2 to (160.37 ± 10.54)% , which was compared to the Parkinson's disease (PD) group (t = 0.109, P = 0.000). The study of immunofluorescent staining revealed that there were few phosphorylation of ERK1/2 in the lesion side of hemiparkinsonian rats, and most of them were expressed in dynorphin ⁃ negative neurons; levodopa administration increased the phosphorylation of ERK1/2 expression compared with the PD group (t = 5.121, P = 0.000), and the co⁃expression of the phosphorylation of ERK1/2 and dynorphin increased to (83.62 ± 1.46)% compared with PD group (t = 11.263, P = 0.003). Conclusion These results suggest that the changes of ERK1/2 phosphorylation state in the strionigral neurons can play an important role in the over ⁃ excitation of the direct pathway medium⁃spiny neurons.

DOI:10.3969/j.issn.1672-6731.2011.01.013

Keywords


Parkinson disease; Dyskinesia, drug ⁃ induced; Protein kinases; Fluorescent antibody technique; Levodopa

Full Text: PDF

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.